Intra sheath corticosteroid injection for De Quervain’s tenosynovitis

Shanmuga Sundaram Pooswamy, Niranjanan Raghavn Muralidharagopalan


Background: De Quervain’s disease or stenosing tenosynovitis of the first dorsal compartment of the wrist is a common condition, which affects the Abductor pollicis longus and the extensor pollicis brevis tendons. There are characteristic signs and symptoms including a positive Finkelstein's test. Different options for treatment include conservative approaches like analgesics, splinting and physical therapy. If conservative options fail then steroid injection is considered.

Methods: This is a retrospective study of single dose intra-sheath triamcinolone and lignocaine injection in 32 patients at our institute who were followed up for a period of 12 months.

Results: In our study there were 25 females and 7 males with a mean age of 46.4±8.03 years. Right side was involved in 17 patients and left side in 15 patients. The pre procedure VAS score was 8.65±1.07. The follow up VAS scores at 1, 6 and 12 months respectively were 1.4±1.14, 0.84±1.06 and 1.03±1.26 respectively. 4 out of 32 patients had positive Finkelstein’s test at 1 year follow up. Common complications were pain at injection site, which was seen in 5/32 patients and depigmentation seen in 2/32 patients.

Conclusions: Thus intra sheath triamcinolone injection is a safe and effective procedure for treatment of De Quervains disease.


De Quervain, Steroid injection, Intra sheath triamcinolone, Failed conservative

Full Text:



De Quervain’s F. On the nature and treatment of stenosing tendovaginitis on the styloid process of the radius. J Hand Surg [Br]. 2005;30:392-4.

De Quervain F. On a form of chronic tendovaginitis. (Translated article: Cor-Bl.f.schweiz. Aerzrte 1895:25:389-94). J Hand Surg [Br]. 2005;30:388-91.

Moore JS. De Quervain's tenosynovitis. Stenosing tenosynovitis of the first dorsal compartment. J Occup Environ Med. 1997;39:990-1002.

Schned ES. De Quervain tenosynovitis in pregnant and postpartum women. Obstet Gynecol. 1986;68:411–894.

Weiss AP, Akelman E, Tabatabai M. Treatment of de Quervain’s disease. J Hand Surg Am. 1994;19:595-8.

Clarke MT, Lyall HA, Grant JW, Matthewson MH. The histopathology of de Quervain's disease. J Hand Surg [Br]. 1998;23(6):732-4.

Palmer K, Walker-Bone K, Linaker C, Reading I, Kellingray S, Coggon D, et al. The Southampton examination schedule for the diagnosis of musculoskeletal disorders of the upper limb. Ann Rheum Dis. 2000;59:5-11.

Richie CA, Eriner WW Jr. Corticosteroid injection for treatment of de Quervain's tenosynovitis:a pooled quantitative literature evaluation. J Am Board Fam Pract. 2003;16:102-6.

Ta KT, Eidelman D, Thomson JG. Patient satisfaction and outcomes of surgery for de Quervain's tenosynovitis. J Hand Surg Am. 1999;24:1071-7.

Carlsson AM. Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale. Pain. 1983;16(1):87-101.

Ilyas AM, Ast M, Schaffer AA. De quervain tenosynovitis of the wrist. J Am Acad Orthop Surg. 2007;15:757–64.

Kitti JI, Sukit S, Kitiwan V, Surut JI. Treatment of De Quervain disease with triamcinolone injection with or without nimesulide. J Bone Joint Surg Am. 2004;86:2700–6.

Froimson A. Tenosynovitis and tennis elbow. In:Green DP (ed) Operative hand surgery, vol. 2, 3rd edn. New York: Churchill Living- stone; 1993: 1989–2006.

Quinnel RC. Conservative management of trigger finger. Practitioner. 1980;224:187–90.

Anderson BC, Manthey R, Brouns MC. Treatment of De Quervain’s tenosynovitis with corticosteroids. A prospective study of the response to local injection. Arthritis Rheum. 1991;34:793–8.

Avci S, Yilmaz C, Sayli U. Comparison of nonsurgical treatment measures for de Quervain's disease of pregnancy and lactation. J Hand Surg [Am]. 2002;27:322-4.

McDermott JD, Ilyas AM, Nazarian LN, Leinberry CF. Ultrasound-guided injections for de Quervain's tenosynovitis. Clin Orthop Relat Res. 2012;470(7):1925-31.

Kamel M, Moghazy K, Eid H, Mansou R. Ultrasonographic diagnosis of de Quervain’s tenosynovitis. Ann Rheum Dis. 2002;61:1034-5.

Jeyapalan K, Choudhary S. Ultrasound-guided injection of triamcinolone and bupivacaine in the management of de Quervain′s disease. Skelet Radiol. 2009;38:1099-103.

Goldfarb CA, Gelberman RH, McKeon K, Chia B, Boyer MI. Extra-articular steroid injection:early patient response and the incidence of are reaction. J Hand Surg Am. 2007;32:1513–20.

Harvey FJ, Harvey PM, Horsley MW. De Quervain’s disease: surgical or nonsurgical treatment. J Hand Surg Am. 1990;15:83-7.

Jackson WT, Viegas SF, Coon TM. Anatomical variation in the First extensor compartment of the wrist:a clinical and anatomical study. J Bone Joint Surg Am. 1986;68:923–6.

Sawaizumi T, Nanno M, Hiromoto IT. De Quervain’s disease: efficacy of intra-sheath triamcinolone injection. Int Orthop. 2007;31(2):265-8.

Pagonis T, Ditsios K, Toli P, Givissis P, Christodoulou A. Improved corticosteroid treatment of recalcitrant de Quervain tenosynovitis with a novel 4-point injection technique. Am J Sports Med. 2011;39(2):398-403.